Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page was published. This appears to be a backend or documentation update rather than a substantive modification to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-11T19:31:52.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    - A new publication citation was added to the Publications section: Silverberg JI, Prajapati VH, Abraham S, Irvine AD, Gooderham MJ, Guttman-Yassky E, Tanizaki H, Rademaker M, Chen SH, Moreira A, Ta R, Lee WJ, Eyerich K. Achieving Minimal Disease Activity in Atopic Dermatitis Is Associated with Fewer Flares, Reduced Healthcare Resource Utilization, and Improved Disease Control: Analysis from the Real-World MEASURE-AD Study. Dermatol Ther (Heidelb). 2026 Jul 30. Online ahead of print.
    Difference
    0.0%
    Check dated 2026-08-04T16:32:38.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision identifier was updated to v3.6.4, signaling a platform or content release update. This update does not modify study details, eligibility criteria, or displayed results.
    Difference
    0.0%
    Check dated 2026-07-21T12:39:21.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Added a new publication entry for Upadacitinib efficacy in atopic dermatitis (head and neck region). Revisions indicate the current version is v3.6.3 and the older May 24, 2026 online-ahead-of-print citation (v3.6.0) was removed.
    Difference
    0.0%
    Check dated 2026-06-30T00:44:25.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Following the interim analysis, significant noncompliance was identified at a clinical site, and all data from that site (including data from 10 adolescent participants) has been excluded from the final analysis of the outcome measures as appropriate. The update also adds specific site locations (e.g., Sofia, Bulgaria; Kota Kinabalu, Sabah, Malaysia) and AbbVie’s data-sharing disclosures and related links.
    Difference
    0.5%
    Check dated 2026-06-22T21:53:49.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The study is now listed as No longer looking for participants, indicating that recruitment has closed and enrollment is no longer possible. The page also adds navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows an updated Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-15T18:01:28.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.